TY - JOUR
T1 - Genetic predictors of circulating 25-hydroxyvitamin D and prognosis after colorectal cancer
AU - Neumeyer, Sonja
AU - Butterbach, Katja
AU - Banbury, Barbara L.
AU - Berndt, Sonja I.
AU - Campbell, Peter T.
AU - Chlebowski, Rowan T.
AU - Chan, Andrew T.
AU - Giovannucci, Edward L.
AU - Joshi, Amit D.
AU - Ogino, Shuji
AU - Song, Mingyang
AU - McCullough, Marjorie L.
AU - Maalmi, Haifa
AU - Manson, Jo Ann E.
AU - Sakoda, Lori C.
AU - Schoen, Robert E.
AU - Slattery, Martha L.
AU - White, Emily
AU - Win, Aung K.
AU - Figueiredo, Jane C.
AU - Hopper, John L.
AU - Macrae, Finlay A.
AU - Peters, Ulrike
AU - Brenner, Hermann
AU - Hoffmeister, Michael
AU - Newcomb, Polly A.
AU - Chang-Claude, Jenny
N1 - Funding Information:
DACHS: This work was supported by the German Research Council (BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1, HO 5117/2-1, HE 5998/2-1, KL 2354/3-1, RO 2270/8-1, and BR 1704/17-1); the Interdisciplinary Research Program of the National Center for Tumor Diseases (NCT), Germany; and the German Federal Ministry of Education and Research (01KH0404, 01ER0814, 01ER0815, 01ER1505A, and 01ER1505B). DALS: NIH (R01 CA48998 to M.L. Slattery).
Funding Information:
Harvard cohorts (HPFS, NHS, PHS): HPFS is supported by the NIH (P01 CA055075, UM1 CA167552, U01 CA167552, R01 CA137178, R01 CA151993, and R35CA197735), NHS by the NIH (R01 CA137178, P01 CA087969, UM1 CA186107, R01 CA151993, and R35 CA197735), and PHS by the NIH (R01 CA042182).
Funding Information:
PLCO: Intramural Research Program of the Division of Cancer Epidemiology and Genetics and supported by contracts from the Division of Cancer Prevention, NCI, NIH.
Funding Information:
WHI: The WHI program is funded by the National Heart, Lung, and Blood Institute, NIH, U.S. Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C.
Funding Information:
Fred Hutch core grant: This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA015704.
Publisher Copyright:
© 2020 American Association for Cancer Research.
PY - 2020/6
Y1 - 2020/6
N2 - Background: Low serum 25-hydroxyvitamin D [25(OH)D] concentrations in patients with colorectal cancer have been consistently associated with higher mortality in observational studies. It is unclear whether low 25(OH)D levels directly influence colorectal cancer mortality. To minimize bias, we use genetic variants associated with vitamin D levels to evaluate the association with overall and colorectal cancer–specific survival. Methods: Six genetic variants have been robustly identified to be associated with 25(OH)D levels in genome-wide association studies. On the basis of data from the International Survival Analysis in Colorectal Cancer Consortium, the individual genetic variants and a weighted genetic risk score were tested for association with overall and colorectal cancer–specific survival using Cox proportional hazards models in 7,657 patients with stage I to IV colorectal cancer, of whom 2,438 died from any cause and 1,648 died from colorectal cancer. Results: The 25(OH)D decreasing allele of SNP rs2282679 (GC gene, encodes group-specific component/vitamin D–binding protein) was associated with poorer colorectal cancer–specific survival, although not significant after multiple-testing correction. None of the other five SNPs showed an association. The genetic risk score showed nonsignificant associations with increased overall [HR ¼ 1.54; confidence interval (CI), 0.86–2.78] and colorectal cancer–specific mortality (HR ¼ 1.76; 95% CI, 0.86–3.58). A significant increased risk of overall mortality was observed in women (HR ¼ 3.26; 95% CI, 1.45–7.33; Pheterogeneity ¼ 0.01) and normal-weight individuals (HR ¼ 4.14; 95% CI, 1.50–11.43, Pheterogeneity ¼ 0.02). Conclusions: Our results provided little evidence for an association of genetic predisposition of lower vitamin D levels with increased overall or colorectal cancer–specific survival, although power might have been an issue. Impact: Further studies are warranted to investigate the association in specific subgroups.
AB - Background: Low serum 25-hydroxyvitamin D [25(OH)D] concentrations in patients with colorectal cancer have been consistently associated with higher mortality in observational studies. It is unclear whether low 25(OH)D levels directly influence colorectal cancer mortality. To minimize bias, we use genetic variants associated with vitamin D levels to evaluate the association with overall and colorectal cancer–specific survival. Methods: Six genetic variants have been robustly identified to be associated with 25(OH)D levels in genome-wide association studies. On the basis of data from the International Survival Analysis in Colorectal Cancer Consortium, the individual genetic variants and a weighted genetic risk score were tested for association with overall and colorectal cancer–specific survival using Cox proportional hazards models in 7,657 patients with stage I to IV colorectal cancer, of whom 2,438 died from any cause and 1,648 died from colorectal cancer. Results: The 25(OH)D decreasing allele of SNP rs2282679 (GC gene, encodes group-specific component/vitamin D–binding protein) was associated with poorer colorectal cancer–specific survival, although not significant after multiple-testing correction. None of the other five SNPs showed an association. The genetic risk score showed nonsignificant associations with increased overall [HR ¼ 1.54; confidence interval (CI), 0.86–2.78] and colorectal cancer–specific mortality (HR ¼ 1.76; 95% CI, 0.86–3.58). A significant increased risk of overall mortality was observed in women (HR ¼ 3.26; 95% CI, 1.45–7.33; Pheterogeneity ¼ 0.01) and normal-weight individuals (HR ¼ 4.14; 95% CI, 1.50–11.43, Pheterogeneity ¼ 0.02). Conclusions: Our results provided little evidence for an association of genetic predisposition of lower vitamin D levels with increased overall or colorectal cancer–specific survival, although power might have been an issue. Impact: Further studies are warranted to investigate the association in specific subgroups.
UR - http://www.scopus.com/inward/record.url?scp=85085904012&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085904012&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-19-1409
DO - 10.1158/1055-9965.EPI-19-1409
M3 - Article
C2 - 32188599
AN - SCOPUS:85085904012
SN - 1055-9965
VL - 29
SP - 1128
EP - 1134
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 6
ER -